Global Brain Tumor Diagnostics Market 2024-2028
Brain Tumor Diagnostics Market 2024-2028
The brain tumor diagnostics market is forecasted to grow by USD 152.9 mn during 2023-2028, accelerating at a CAGR of 3.4% during the forecast period. The report on the brain tumor diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of brain cancer, increasing prevalence of neurological disorders, and growing importance of tele-imaging.
Technavio's brain tumor diagnostics market is segmented as below:
By Type
- Imaging test
- Biopsy
- Molecular testing
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increase in research and development and advances in technology as one of the prime reasons driving the brain tumor diagnostics market growth during the next few years. Also, integration of artificial intelligence (AI) with diagnostic imaging and focus on emerging countries will lead to sizable demand in the market.
The report on the brain tumor diagnostics market covers the following areas:
- Brain Tumor Diagnostics Market sizing
- Brain Tumor Diagnostics Market forecast
- Brain Tumor Diagnostics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading brain tumor diagnostics market vendors that include Amgen Inc., AstraZeneca Plc, Biocept Inc., Canon Inc., FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Hitachi Ltd., Hologic Inc., Koninklijke Philips N.V., MDXHEALTH SA, Merck and Co. Inc., NantOmics, Neusoft Medical Systems Co. Ltd., Pfizer Inc., Shimadzu Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. Also, the brain tumor diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.